{"organizations": ["University of Oxford", "Merrimack Pharmaceuticals,Inc.", "Salk Institute for Biological", "Perrigo Company", "Inc", "Heart State Health Department", "Oxford Gene Technology", "Pennsylvania Department of Health", "State Police", "AccentHealth Exam Room Tablet", "Perrigo Perrigo Company", "Isolagen Therapy", "Isolagen", "Perrigo Company plc", "Horizon Blue Cross Blue Shield", "The Morgan Stanley 2015 Global Healthcare Conference", "Brownsville Tri-County Hospital Charleston", "Point of Care", "University of Cambridge", "AccentHealth", "Major New Alliance Formed to Transform How Health Care", "Protein Array Technology", "Sengenics Acquires Oxford Gene Technology", "Merrimack Pharmaceuticals"], "uuid": "5f4578ff580b0aed23870b6ab35b501ae4e9080f", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.bio-medicine.org", "main_image": "", "site_section": "http://feeds.bio-medicine.org/latest-medical-technology", "section_title": "Latest Medical Technology from Bio-Medicine.Org", "url": "http://www.bio-medicine.org/medicine-technology-1/Acute-Ischemic-Stroke-Diagnosis-and-Treatment-Market-to-Amount-to-US-241-9-Billion--Propelled-by-Growing-Cases-of-Acute-Ischemic-Stroke-3A-Transparenc-48223-1/", "country": "US", "title": "Acute Ischemic Stroke Diagnosis and Treatment Market to Amount to US$1.9 Billion, Propelled by Growing Cases of Acute Ischemic Stroke: Transparency Market Research", "performance_score": 0, "site": "bio-medicine.org", "participants_count": 0, "title_full": "Acute Ischemic Stroke Diagnosis and Treatment Market to Amount to US$1.9 Billion, Propelled by Growing Cases of Acute Ischemic Stroke: Transparency Market Research", "spam_score": 0.0, "site_type": "news", "published": "2015-09-10T17:38:00.000+03:00", "replies_count": 0, "uuid": "5f4578ff580b0aed23870b6ab35b501ae4e9080f"}, "author": "", "url": "http://www.bio-medicine.org/medicine-technology-1/Acute-Ischemic-Stroke-Diagnosis-and-Treatment-Market-to-Amount-to-US-241-9-Billion--Propelled-by-Growing-Cases-of-Acute-Ischemic-Stroke-3A-Transparenc-48223-1/", "ord_in_thread": 0, "title": "Acute Ischemic Stroke Diagnosis and Treatment Market to Amount to US$1.9 Billion, Propelled by Growing Cases of Acute Ischemic Stroke: Transparency Market Research", "locations": ["Fayette County", "NY", "Downtown Chicago", "Charleston", "Brownsville", "Mass.", "Chicago", "Inc.", "New Jersey", "Pennsylvania", "China"], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": ["Matthew Markham", "Joseph C. Papa", "Marvin Berlin", "Jeff Lynch"], "text": "  10, 2015 Perrigo Company plc (NYSE: ... and CEO Joseph C. Papa will present ... 12:55 PM EDT on Thursday, September 17, 2015 at ... City , NY. Interested parties can access the ... About Perrigo Perrigo Company plc   2015 The Pennsylvania ... drugs Sat., Sept. 12, as part of National Prescription ... no questions asked. Take-Back Day is a ... Enforcement Administration (DEA), aimed at encouraging the public to ... are prone to abuse and theft. From   10, 2015 MEDTEC China 2015 is ... Convention Center with the objectives to upgrade ... and providing a highly efficient platform for communication and ... of the Chinese medical device industry. ... The exhibition scale of MEDTEC China ... [ 0 ] Perrigo Company To Present At The Morgan Stanley 2015 Global Healthcare Conference [ 0 ] State Police Accepting Expired, Unwanted Prescription Medications Saturday [ 0 ] MEDTEC China Adopts The Latest Technology - Provides Efficient Business Matching Service ... Mass., March 14 Merrimack Pharmaceuticals,Inc. today announced ... 2 trial,of 100 patients that evaluates the safety ... suffering from rheumatoid arthritis (RA). MM-093 is a,recombinant ... double-blind, placebo-controlled, Phase 2 study is,being conducted at ... ... 14 Isolagen(TM), Inc.,(Amex: ILE ) announced ... in its Phase II/III Study IT-A-008 investigating the ... acne scars. Treatments,which will be administered at seven ... \"We believe the Isolagen Therapy could hold great ... Merrimack Pharmaceuticals Completes Enrollment in a Phase 2 Study of MM-093 in Patients with Rheumatoid Arthritis Isolagen, Inc. Completes Enrollment in Isolagen Therapy(TM) Phase II/III Acne Scar Study (Date:9/10/2015)...   The ... the use of health IT to create efficiencies in healthcare information exchange, announced ... ICD-10 including the ICD-10 State Workers’ Compensation Readiness List and the   Horizon Blue Cross Blue Shield ... a major multispecialty physician group announced today that they have formed a unique, ... health care is financed and delivered in New Jersey to reward value, which   ,   ... acquisition of Oxford Gene Technology’s (OGT) protein array technology, a patented auto-antibody profiling ... collaboration between the University of Oxford and the University of Cambridge in 1996.   AccentHealth, the leader in patient education ... patient engagement platform, the AccentHealth Exam Room Tablet, as part of the industry’s most ... minutes waiting in an exam room before their physician arrives, and AccentHealth’s digital tablet   ... , ... Parallel 6 , an enterprise mobile technology company, announced today ... a security posture that has upheld scrutiny in the highest levels of the United ... Reach platform is designed to encrypt data, from the patient’s internet enabled device to ... [ 0 ] WEDI Releases State ICD-10 Readiness Resources [ 0 ] Major New Alliance Formed to Transform How Health Care is Delivered and Financed in New Jersey [ 0 ] Sengenics Acquires Oxford Gene Technology’s Protein Array Technology and Announces Global Rebrand to Immunome™ [ 0 ] New Exam Room Tablet from AccentHealth Provides Comprehensive Solution To Help Educate and Engage Patients at the Point of Care [ 0 ] Parallel 6’s End-to-End Patient Recruitment, Engagement & Retention Solution, Clinical Reach, Increases Security and Privacy of Patient Information during Clinical Trials ... most of their genes, including 70 percent of all ... evolutionary conservation, researchers at the Salk Institute for Biological ... for an innovative study of gliomas, the most common ... but we still know very little about the underlying ... ... Results are better with brief immobilization than with bandage or ... People with severe ankle sprains recover faster with a short ... brace than with the use of either a tubular compression ... , Along with receiving one of the four ... ... 12 On March 1st, Insight Psychological Centers, LLC ... Partial Hospitalization Program (PHP) for anxiety and mood disorders. ... in Chicago, Insight,s intensive program will be offered in ... to work, avoid taking disability leave, and continue participating ... ... Dr. Marvin Berlin is out to,change lives by ... as he,hosts the latest event for Dentistry From The ... event will take place on Saturday, Feb. 14 at,McKinneyDentist.com ... his,partners, including Dr. Matthew Markham, Dr. Jeff Lynch, and ... ... Pennsylvania Department of Health has reviewed and approved ... in Brownsville, Fayette County, which ceased operations today.All ... been relocated to other facilities. All hospital staff, ... assisted with the patient transfer.Local ambulances and emergency ... ... Inc, an,emerging specialty pharmaceutical company dedicated to reducing ... preliminary,findings from its development and testing of an ... in Charleston,s clinical trials. , ... test the feasibility and,reliability of the OSQ,\" reported ... Fruit flies soar as lab model, drug screen for the deadliest of human brain cancers Casting Seems Best for Severe Ankle Sprains New Anxiety and Mood Disorders Intensive Treatment Program in Downtown Chicago McKinneyDentist.com Hosts Free Day of Dentistry With Dentistry From The Heart State Health Department Approves Closure Plan for Brownsville Tri-County Hospital Charleston Conducts Evaluation of an Opioid Symptoms Questionnaire H2003 manage your patient records and billing processes via the Web.... ... The OmniMD Medical Billing system allows ... and accounting. It is integrated with ... capture. The system interfaces with electronic ... tracking. With a set of reports, ... ... athenaCollector is athenahealth's revenue ... solution. It provides medical ... capabilities in the industry. ... and billing processes are ... ... The Infinity Urea (Nitrogen) powder reagent ... convenience of single liquid stability to help ... provide quick result turnaround time. The patented ... reagent provides a long shelf life and ...", "external_links": [], "published": "2015-09-10T17:38:00.000+03:00", "crawled": "2015-09-10T19:38:03.001+03:00", "highlightTitle": ""}